Patent · US Active

Anti-ANG2 antibodies and methods of use

US10538585B2 · kind B2 · utility

2Cited by

7References

6Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Stefan Dengl · Munich, DE
Guy Georges · Habach, DE
Peter Michael Huelsmann · Habach, DE
Hubert Kettenberger · Munich, DE
Joerg Moelleken · Penzberg, DE
Michael Molhoj · Munich, DE
Joerg Thomas Regula · Munich, DE

Key dates

Filing date	May 10, 2017
Grant date	Jan 21, 2020
Priority date	—
Expiry date	May 10, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Herein are reported anti-ANG2 antibodies. A specific anti-ANG2 antibody comprises (a) a HVR-H1 comprising the amino acid sequence of SEQ ID NO: 20, (b) a HVR-H2 comprising the amino acid sequence of SEQ ID NO: 21, and (c) a HVR-H3 comprising the amino acid sequence of SEQ ID NO: 23.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.